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Until now, no clonal cells have been identified that support the
expression of a marker gene expressed from the rat preprota-
chykinin A (rPPT) promoter. We have analysed recently available
cell lines that are candidates for supporting reporter gene
expression directed by the rPPT promoter. These are the
neuronal-derived cell line NF2C and the pancreatic cell lines
RINm5F and a derivative RIN-1027-B2. The NF2C line was
derived from the brain homogenate of a transgenic animal in
which a temperature-sensitive simian virus 40 large T antigen
was expressed from a neurofilament promoter. All three lines are
able to support expression of a reporter gene directed by a
fragment of the 5« rPPT promoter. Analysis of reporter gene
expression supported by various fragments of the rPPT promoter
demonstrated that although fi865 to ›92 bp supported ex-
INTRODUCTION
The gene for rat preprotachykinin A (rPPT) encodes the neuro-
peptides substance P, neurokinin A, neuropeptide K and neuro-
peptide c, which are derived by alternative splicing of primary
RNA transcripts and post-translational processing of the peptide
precursors [1,2]. Analysis of rPPT promoter activity has been
hindered by the lack of a clonal cell line that either expressed the
endogenous gene or allowed the expression of a reporter gene
supported by fragments of the rPPT promoter [3–6]. It has
previously been shown that the proximal rPPT promoter, when
linked to a reporter gene, directs high levels of expression in
microinjected rat dorsal root ganglion neurons (DRG) grown in
tissue culture [3,4]. Microinjection of constructs into DRG is,
however, time consuming, difficult and permits the analysis of
only a few cells. In addition, the heterogeneity of primary cell
cultures and the fact that the rPPT gene is only expressed in a
subset of these neurons add a further complexity to this analysis.
It would be desirable to have a clonal cell line in which the rPPT
promoter is active to complement these studies. Such a cell line
would also provide sufficient protein extract for the biochemical
analysis of the transcription factors interacting directly with the
rPPT promoter and for the dissection of the signal transduction
pathways regulating tachykinin gene expression. To this end we
have been trying to develop clonal cell line models that support
reporter gene expression directed by the rPPT promoter. These
are the neuronal-derived cell line NF2C, and the pancreatic cell
lines RINm5F and a derivative RIN-1027-B2. The NF2C line
Abbreviations used: rPPT, rat preprotachykinin A; DRG, dorsal root ganglion neurons; SV40, simian virus 40 ; LT, large T; CMV, cytomegalovirus ;
CAT, chloramphenicol acetyltransferase.
1 To whom correspondence should be addressed (e-mail jquinn!ed.ac.uk).
pression, the addition of fragments between ›92 and ›447 bp
led to repression of expression. Subsequent analysis of reporter
gene constructs microinjected into primary cultures of dorsal
root ganglion neurons (DRG) confirmed the existence of this
repressor domain. This repression could be relieved totally in
both RIN cell lines and partly in NF2C cells by mutating
residues between ›373 and ›396 bp. This indicates that these
cell lines support PPT promoter activity similar to that observed
in DRG and determines a novel repressor domain within the
promoter.
Key words: dorsal root ganglion neurons, NF2C cell lines, RIN
cells, substance P, tachykinin.
was derived from the brain homogenate of a transgenic animal in
which a temperature-sensitive simian virus 40 (SV40) large T
(LT) antigen is expressed from a neurofilament promoter. The
RIN cells are believed to reflect a more embryonic feature of the
pancrease because PPT gene expression is observed in this organ
during development but not in the normal adult [7].
Initial analysis of rPPT promoter activity focused on the
ability of a proximal promoter region spanning fi3356 to
›447 bp (sequencing has confirmed the exact positioning of the
region previously designated broadly as fi3500 to ›500 [3]) to
support reporter gene expression in the neurons of primary
cultures of DRG but not in the non-neuronal cells of these
heterogeneous cultures [3]. The fragment spanning fi3356 to
›447 had three times more activity than fi3356 to ›92. Further
demonstration that fragments spanning fi3356 to ›92 and
fi865 to ›92 supported equivalent levels of reporter gene
expression in DRG concentrated our biochemical and functional
dissection of the promoter on the region of the promoter spanning
fi865 to ›447 [5,6]. We have previously defined potential
transcription factor interactions with this region biochemically
with the use of DNAase 1 footprint analysis and electrophoretic
mobility-shift analysis, as reviewed in [6]. Until now we have
been unable to demonstrate reporter gene expression in any cell
line, including those of neuronal origin generated by the fusion
of DRG and a neuroblastoma cell line [8]. This restricted tissue-
specific expression is regulated by the combinatorial action of
multiple positive and negative cis-acting regulatory domains
[4,9–18]. A major determinant of this restriction of expression to
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DRG in transient reporter gene analysis is a dominant repressor
protein that binds adjacent to the major transcriptional start site
[4]. Fragments spanning the region fi865 to ›447 have now
been used in reporter gene analysis of the above candidate cell
lines that might support PPT promoter activity.
MATERIALS AND METHODS
Reporter gene constructs
rPPT fragments spanning nt fi47 to ›92 (MINPPT), fi865 to
›92 (5«PPT) and fi865 to ›447 (LPPT) were cloned into the
XhoI site of the pGL3 basic vector (pGL3b; Promega) upstream
of a cloned luciferase reporter gene. In addition, a mutated form
of LPPT (LPPTmu), in which residues ›373 to ›378 and ›391
to ›396 were altered to BglII and BamHI restriction sites
respectively by means of PCR (Figure 1), was also cloned into
pGL3b. All final constructs were confirmed by restriction-enzyme
analysis and sequencing. The pGL3b vector lacks eukaryotic
promoter or enhancer sequences, so the insertion of a functional
promoter at the XhoI}HindIII site will direct the expression of
the reporter gene. The first ATG codon encountered after
transcriptional initiation is within the luciferase gene, as the first
Figure 1 PCR-directed site-specific mutagenesis of LPPT
(A) The mutated region of LPPT is shown spanning nt ›367 to ›403. Mutation of LPPT gives rise to new Bgl II and BamHI restriction-enzyme sites shown in bold in the mutant LPPTmu
sequence. Unaltered nucleotides match in the two sequences. (B) Nucleotide positions of the PCR primers used for creating the mutations. 5«s and 3«a correspond to the ends of LPPT with Xho I
restriction-enzyme sites added for cloning purposes. Mu-s and its anti-sense strand Mu-a (not shown) are the PCR primers containing Bgl II and BamHI sites. (C) Scheme illustrating the PCR
steps required for the creation of muLPPT. Initial PCR reactions created two short products each incorporating one of the mutant primer sequences. When mixed together in very dilute solution
these products anneal, giving rise to LPPTmu after PCR with the flanking 5«s and 3«a primers.
ATG in the rPPT gene is after ›447 and within exon 2 at
position ›611.
Culture of cell lines
NF2C cells (TCS Biologicals) were incubated at 34 °C with
air}CO
#
(19:1) in Dulbecco’s modified Eagle’s medium supple-
mented with 50 ng}ml insulin, 2 mM glutamine, penicillin}
streptomycin, 10% (v}v) fetal calf serum and 10% (w}v)
neuronal cell growth supplement (TCS Biologicals). Cells were
maintained at 60–80% confluence, being passaged approx. every
3 days. At the appropriate time the cells were transferred to 39 °C
and incubated for 14 days to inactivate the LT antigen and allow
differentiation to a neuronal phenotype.
RINm5F and a derivative RIN-1027-B2 cells were incubated
at 37 °C as described by McGregor et al. [7]. The RINm5F cells
are derived from a rat pancreatic tumour and express the rPPT
gene endogenously, therefore being known as RIN+. The RIN-
1027-B2 cell line is derived from the same rat insulinoma tumour
as the RINm5F but does not express substance P on the basis of
radioimmunoassay and PPT Northern blot analyses, therefore
being known as RIN−.
# 1999 Biochemical Society
849Novel cell lines for preprotachykinin gene expression
Primary cultures of DRG
Dorsal root ganglia were excised from Wistar albino female rats
(aged 4–5 weeks). Finely chopped ganglia in Ham’s F14 medium
plus NaHCO
$
(2 g}l, pH 6–7), were digested for 2 h with 0–125%
(v}v) collagenase}dispase; the digested tissue was then centri-
fuged for 1 min at 1000 rev.}min (150 g). Cells were resuspended
in 1 ml of Saito’s medium diluted in Ham’s F14, then incubated
overnight on plates pretreated with poly-(d-ornithine). Neurons,
which adhered only loosely, were finally replated on poly-(d-
ornithine)}laminin (20 lg}ml) coated plates in fresh Saito’s
medium supplemented with recombinant nerve growth factor
(2 ng}ml).
Transfection by electroporation of NF2C and RIN cells
Four transfection experiments were performed for each cell line,
with quadruplicate samples being transfected on each occasion.
Specific rPPT-pGL3b construct (20 lg) plus 2 lg of cytomegalo-
virus (CMV)–chloramphenicol acetyltransferase (CAT) reporter
gene were used per transfection. Flasks of NF2C cells maintained
at 34 °C or alternatively after 14 days at 39 °C were used for
transfection. Cells were transferred to medium with 0–5% (v}v)
serum for 16 h before electroporation. Cells were trypsin-treated
and resuspended at 2‹10& cells in 800 ll of medium containing
0–5% (v}v) serum. Electroporation was performed in 4 mm
electroporation cuvettes with the use of the EquiBio EasyJect.
An electric pulse of 270 V and a capacitance of 1500 lF were
employed (established as optimum). The cells were then
resuspended immediately in fresh complete medium in new
flasks.
Microinjection of DRG
Reporter plasmid DNA was diluted to 150 lg}ml in 10 mM
Tris}HCl buffer, pH 7–5, and loaded into Eppendorf femtotip
injection pipettes, tip diameter 0–5‡0–2 lm. Microinjection was
performed with an Eppendorf microinjector 5242 and micro-
manipulator 5170 system. Reporter gene constructs were micro-
injected 1–4 days after plating, with a standard injection time of
0–5 s. Micro-injection was performed as described previously [3]
except that cultures were plated on shallow 10 mm diameter
polystyrene wells instead of on glass coverslips. The constructs
were microinjected into 100 DRG per well.
Reporter gene assay
After 48 h at the appropriate temperature, cells were washed
twice with PBS, then lysed with Promega reporter lysis buffer.
After 15 min at room temperature the cell lysate was vortex-
mixed and centrifuged briefly at 10000 g. Supernatants were
stored at fi70 °C. rPPT-directed reporter gene expression was
measured by using the Promega luciferase assay system. Super-
natant (20 ll) was added to 100 ll of luciferase assay reagent in
opaque 96-well plates and the light emission was measured over
a given time interval with the Life Sciences Labsystems
Luminoskan, model RT. The linearity of luciferase detection was
established from standard curves of luciferase activity with the
use of 2-fold serial dilutions of luciferase enzyme from 1 lg}ml.
CAT activity was measured with the Boehringer Mannheim kit
in accordance with the manufacturer’s instructions. Luciferase
results were normalized to CAT values to control for transfection
efficiencies. Results are means‡S.D. for quadruplicate deter-
minations.
PCR
mRNA was isolated from equivalent numbers of cells of each
type using RNAzol (Biogenesis) and cDNA was synthesized with
Boehringer Moloney-murine-leukaemia virus reverse tran-
scriptase under standard conditions. cDNA was amplified with
the primers of Harmar et al. [19] from exon 2 and exon 7
sequences, which include the rPPT mRNA initiation and ter-
mination codons respectively, i.e. sense, 5«-AGAATTCAACAT-
GAAAATCCTCGTG-3« (with an EcoRI site introduced at bases
2–7) ; anti-sense 5«-TGGATCCTCGCGGACACACGCTGGA-
GAT-3« (with a BamHI site introduced at bases 2–7). PCR
parameters were: 3 min at 94 °C; 40 cycles of amplification (45 s
at 94 °C, 45 s at 55 °C, 90 s at 72 °C); followed by 5 min at 72 °C.
RESULTS
Novel cell lines that support rPPT promoter activity
We obtained a novel neuronal cell line, NF2C, from TCS
Biologicals. This NF2C line was generated from a transgenic rat
in which a temperature-sensitive SV40 LT antigen is expressed
under the control of the neurofilament light-chain promoter.
SV40 LT antigen expressed as a transgene has previously been
demonstrated to immortalize cells that had previously proved
very difficult to culture in itro and is the basis of the technology
in the ‘ immortomouse’ [20]. NF2C cells will divide in culture at
34 °C when LT antigen is expressed; however, when moved to a
higher temperature the LT antigen will be inactivated and the
cells will not divide. At the higher temperature the cells undergo
a marked change in morphology and now resemble the DRG
that we grow in culture, i.e. large and round with a light-
refractive cell membrane. The morphological changes take at
least 5 days to be observed, with a stable morphological change
by 14 days. Cell death is observed in some of the population
when the cells are shifted to 39 °C; however, the remaining cells
are then stable for several weeks. The NF2C cells should always
be used at low passage number because continued passage leads
to loss of the morphological changes observed when the cells are
shifted to 39 °C. The cells do not grow well if shifted back to
34 °C after several days at 39 °C.
Attempts have previously been made to produce clonal cells
with the properties of neurons, such as the fusion of primary
culture neurons with neuroblastoma cell lines [8]. Although some
of such cells exhibit some neuronal properties, in our hands all
fail to express the endogenous rPPT gene or support the
expression of reporter gene constructs driven by rPPT promoter
fragments. The RIN+ cells are derived form a rat pancreatic
tumour and express the rPPT gene endogenously [7]. It is believed
that this line reflects a more embryonic feature of the pancreas
because PPT gene expression is observed in this organ in
development but not in the normal adult [21]. The RIN− cell line
is derived from the same rat insulinoma tumour as the RIN+ but
was found not to express substance P on the basis of radio-
immunoassay and PPT Northern blot analyses. Both RIN cell
lines are predominantly homogeneous populations, whereas the
NF2C line that was made from a brain homogenate represents a
number of different cell types. The NF2C cells, both at 34 °C and
at 39 °C, and both RIN cell lines express the endogenous rPPT
gene when analysed by PCR (Figure 2). Under the conditions
used, two splice variants were detected in the RIN cells, whereas
only one was detectable in NF2C and DRG. This is a reflection
of the relative amounts of specific mRNA in the different cell
samples and confirms the potential for the cell lines to support
rPPT transcripts in itro.
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Figure 2 PPT transcripts in rat RIN, NF2C and DRG
rPPT was amplified by PCR with the primers of Harmar et al. [19]. Shown are cDNA from
RINm5F− (lane 2), RINm5F+ (lane 3), NF2C/34 °C (lane 4), NF2C/39 °C (lane 5) and normal
rat DRG (lane 6). Various bands are seen corresponding to the major splice products in each
tissue type. The sizes of molecular mass standards (lane 1) are shown at the left.
Table 1 Luciferase expression from MINPPT in NF2C and RIN cell lines
Cells were electroporated with vectors pGL3b, pGL3p or the construct MINPPT plus CMV–CAT
in four separate experiments. Each experiment comprised quadruplicate wells for each
construct. Combined data are shown as mean units of luciferase per experiment (means‡S.D.)
expressed from the reporter gene in the different cell types after 48 h of incubation. All results
have been normalized to CAT expression to correct for transfection efficiencies.
Normalized luciferase activity (units)
Vector NF2C/34 NF2C/39 RIN+ RIN−
pGL3b 17–40‡0–86 1–01‡0–07 0–12‡0–04 1–47‡0–91
MINPPT 39–12‡0–21 2–55‡0–09 1–18‡0–05 33–43‡1–85
pGL3p 110–00‡28–86 6–79‡1–03 0–49‡0–01 5–10‡0–95
Table 2 Reporter gene expression from 5«PPT, LPPT and LPPTmu
constructs in NF2C, RIN and DRG
Results are expressed as fold luciferase units relative to that from MINPPT in each cell line.
NF2C and RIN cells were electroporated in quadruplicate for each construct and DRG were
microinjected with constructs plus CMV–CAT. Electroporation data are means‡S.D. for four
separate experiments except DRG results, which are per 100 cells injected. All results are
normalized to CAT expression. Abbreviation : n.d., not determined.
Normalized luciferase units (fold)
Construct NF2C/34 NF2C/39 RIN+ RIN− DRG (100 cells)
MINPPT 1 1 1 1 1
5«PPT 5–80‡0–31 6–90‡1–45 3–56‡1–25 5–15‡1–47 12–2
LPPT 2–24‡0–73 2–67‡1–12 0–48‡0–02 0–44‡0–03 2–74
LPPTmu 4–23‡1–11 4–75‡0–98 3–80‡0–76 5–64‡1–01 n.d.
The rat tachykinin promoter fragment spanning fi865 to ›92
has supported reporter gene expression in primary cultures of
DRG but not in any cell line previously tested [4,22], with the
exception of PC12 cells exposed to the synergistic action of
forskolin and potassium-evoked depolarization [9]. In all three
lines tested here, and at both temperatures in the NF2C model,
this promoter fragment supported high levels of expression
(Tables 1 and 2). The minimal promoter, fi47 to ›92, supported
levels of expression significantly higher than backgrounds
obtained from transfection of the pGL3b vector, suggesting
that this element has the ability to support expression in
these cells (Table 1). This is distinct from the effects of the
minimal promoter in cell lines tested previously, in which
the minimal promoter appears as no higher than background
levels of reporter gene expression [4].
Although all cells supported expression directed by the rPPT
promoter, the absolute level of reporter gene expression varied
between the different cell types. NF2C that were transfected 14
days after being shifted to 39 °C exhibited a tenfold lower level
of reporter gene expression than that seen with cells left at 34 °C.
Similarly, the level of expression in the RIN+ and RIN− cells
differed by an order of magnitude irrespective of the reporter
construct used. We believe this reflects a difference in transfection
efficiency because the Promega promoter vector (pGL3p), in
which luciferase expression is under the control of the SV40
promoter, was affected similarly, as seen in Table 1.
Presence of a repressor domain 3« of the major transcriptional
start site
To address the role of the previously hypothesized regulatory
elements present 3« of the major transcriptional start site [15], the
LPPT reporter gene construct was used in all three cell lines.
Expression directed by the three constructs, MINPPT (fi47 to
›92), 5«PPT (fi865 to ›92) and LPPT (fi865 to ›447), was
compared. Although all the cells supported the expression of
each of the constructs, addition of the region spanning ›92 to
›447 acted as a repressor of transcription in all cells tested
(Table 2). This repression was most marked in both RIN cell
derivatives in which reporter gene expression supported by LPPT
construct was less than that of the MINPPT construct. In the
neuronal cell line, although the longer fragment still supported
significant reporter expression compared with that of the
MINPPT construct, it was decreased by at least 50% relative to
the truncated construct, 5«PPT. This was surprising because it
had previously been demonstrated by us and others that the
addition of sequences from ›92 to ›500 acted as an enhancer
in primary cultures of DRG in the context of a promoter
fragment spanning fi3500 to ›500 [3]. We therefore addressed
the ability of the LPPT construct to drive expression in primary
cultures of rat DRG. All three PPT reporter constructs were
microinjected and the levels of luciferase activity were measured
48 h after injection. The results are similar to those observed in
the NF2C cell line, in that a 3« repressor was present between
›92 and ›447, although the LPPT construct still supported
reporter gene expression.
Mutation of nucleotides between ›373 and ›396 relieves the
repression of LPPT
We have initiated an analysis of the function of previously
published transcription factor binding sites [6] in the NF2C and
RIN cell lines. One region in particular, between ›373 and
›396 of LPPT, which has previously been identified by DNAase
I footprint analysis, is of interest in the current context [15]. The
sequence of this region has been demonstrated to bind several
proteins including Oct1 and nuclear factor jB. We made several
mutations in this region that not only might affect transcription
factor binding to this region but would also allow us, if required,
to make further modifications by using the newly generated
restriction enzyme sites. The resultant LPPTmu was used for
transfection analyses in NF2C and RIN cells. In all cases,
mutation of residues ›373 to ›378 and ›391 to ›396 led to
increased reporter gene expression relative to the wild-type
construct, the effect again being most marked in the two RIN cell
lines (Table 2). In NF2C cells some measure of repression was
still present, whereas in both RINs the repression was completely
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abolished. The fact that LPPTmu and 5«PPT were able to
support equivalent levels of expression shows that the addition of
the 355 nt from ›92 to ›447 is not a factor that in itself
decreases reporter gene expression. It is therefore apparent that
the region between ›373 and ›396 contains residues responsible
for the strong repression of the LPPT construct. We have not
determined the specific repressor molecule because several com-
plexes bind to this region.
DISCUSSION
We have generated clonal cell line models in which to study rPPT
gene expression. The cell lines express the endogenous gene and
support transient gene expression directed by rPPT promoter
fragments in reporter gene constructs. The NF2C cell line in
particular might be a useful model delineating regulatory mech-
anisms that modulate rPPT promoter activity in neurons. The
RIN cell lines might represent the dysregulation of rPPT pro-
moter activity seen in tumours that exhibit a neuroendocrine
phenotype [23–26] or they might reflect some developmental
regulatory mechanisms operating on the rPPT promoter [21]. It
is likely that the NF2C cells will be of more general use for
analysis of neuronal gene expression because they have been
reported to up-regulate the expression of neuronal markers on
differentiation at 39 °C. Markers observed are neuronal specific
enolase, synaptophysin, mitogen-activated protein 2, tau and
neurofilament (TCS product information). These cell lines will be
an invaluable source for biochemical characterization of the cis-
acting domains regulating rPPT promoter activity and the
subsequent identification of the factors binding to these elements.
Although all cells supported expression directed by the rPPT
promoter, the absolute level of reporter gene expression varied
between the different cell types. NF2C that were transfected 14
days after being shifted to 39 °C exhibited a log lower level of
reporter gene expression than that of cells left at 34 °C. Although
not extensively analysed, this could be related to the mor-
phological changes in the cells, reflecting the same resistance to
transfection observed with primary cultures of neurons ([4,22] ;
J. P. Quinn, unpublished work) or alternatively being due to
altered expression at the higher temperature. The RIN+ and RIN−
cells also showed levels of expression that differed by an order of
magnitude irrespective of the reporter construct used. We believe
that this reflects a difference in transfection efficiency because the
Promega promoter vector (pGL3p), which uses the SV40 pro-
moter, was similarly affected.
Microinjection of rPPT reporter gene constructs into DRG
has previously established the expression patterns elicited by
various rPPT fragments between fi3356 and ›447 [3]. The
current study has shown the presence of a previously unidentified
repressor domain that is 3« of the major transcriptional start site
and is apparent with the NF2C and both RIN cell lines when
transfected with the fi865 to ›447 LPPT construct. This
repressor function was also observed when the same constructs
were microinjected into primary cultures of adult rat DRG. It
should be noted that this repressor only affects the relative levels
of reporter gene expression because the LPPT construct (fi865
to ›447) still shows a 3-fold increase over the minimum PPT
construct (fi47 to ›92) in DRG. The ability of this domain to
repress reporter gene expression also varied between the rat
DRG and the cell lines. Specifically this was highlighted in both
of the RIN cell lines in which addition of the 3« domain completely
negated reporter gene expression. Use of the mutant LPPTmu
construct demonstrated that a major determinant of this re-
pression lies within a short region between ›373 and ›396 of
the rPPT promoter. The repressor therefore seems to exert a
much greater effect in the non-neuronal RIN+ and RIN− cells
than in the neuronal NF2C cells and DRG, which show
respectively only 61–4% and 77–5% repression of the LPPT
construct relative to the 5«PPT (fi865 to ›92) construct (Table
2). This result suggests a tissue-specific determinant regulating
this transcriptional mechanism. Despite these differences in levels
of repression, the overall trends and patterns of expression in all
the cells tested here are remarkably similar.
It was of some surprise that analysis of a reporter gene
construct spanning fi865 to ›447 in these lines revealed a
repressor domain that is 3« of the major transcriptional start site.
Previous microinjection of reporter gene constructs into primary
cultures of adult rat DRGdemonstrated that the largest promoter
fragments, spanning fi3356 to ›447, supported 3-fold greater
expression than fragments spanning fi865 to ›92 or fi3356 to
›92. We therefore hypothesize that element(s) spanning fi3356
to fi865 are able to overcome the effects of the 3« repressor but
elucidating this mechanism is not within the scope of the present
study.
Preliminary EMSA results with wild-type and mutated oligo-
nucleotides designed to encompass the region ›367 to ›399
have shown the presence of a number of complexes with the
various cell extracts. The wild-type and mutated oligonucleotides
yield slightly different band patterns ; the banding patterns also
vary slightly between the cell types. This rPPT region has
previously been characterized as containing multiple complexes
and includes Oct1- and nuclear factor jB-binding sites [15]. The
relevance of the different complexes to the proposed repressor
binding protein is the subject of a separate and continuing study.
The results presented here validate the use of these cell-line
model systems for studying rPPT expression because of the
coincidence of patterns of receptor gene expression between the
cell lines and DRG. Cell cultures, like the primary cultures, only
offer a model for addressing potential transcriptional control
mechanisms. These will still have to be further validated in io.
These current results further our previous observations and the
hypothesis that the rPPT promoter is regulated by the synergistic
action of multiple positive and negative regulators that are likely
to be regulated in both a tissue-specific and a stimulus-inducible
manner. Having two different cell models, each of which can
provide information about potential interactions with the rPPT
promoter, will be an invaluable resource for dissecting out
different aspects of the complex tissue-specific expression of
rPPT.Further biochemical characterization of these transcription
factors in the cell-line models will complement the biological
significance of these regulators in io.
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